Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 857.55
-9.15 (-1.06%)
Nov 12, 2026, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 51.35 billion as of November 12, 2026. It is the 13,735th most valuable company in the world and the 833rd biggest in India. Its market cap has increased by 23.28% in one year.
Market Cap
51.35B
Enterprise Value
54.15B
Revenue
8.52B
Global Rank
Country Rank
#833 India
PE Ratio
147.51
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 51.35B, an increase of 6,960.52%. That is a compound annual growth rate of 102.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 51.35B | 33.41% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 117.89B |
| Strides Pharma Science | 91.74B |
| Aarti Pharmalabs | 84.33B |
| Sun Pharma Advanced Research Company | 67.88B |
| Innova Captab | 62.66B |
| RPG Life Sciences | 42.84B |
| Solara Active Pharma Sciences | 32.30B |
| Ind-Swift Laboratories | 31.74B |